SCHEMBL388496

SCHEMBL388496

O=C(OO)C1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1268174 1.00
SCHEMBL464808 1.00
SCHEMBL28080548 0.93 NOS2 (0.39)
SCHEMBL2494402 0.84 NOS2 (0.43)
SCHEMBL6859669 0.84 NOS2 (0.46)
SCHEMBL995604 0.84 NOS2 (0.46)
SCHEMBL146828 0.84 NOS2 (0.46)
SCHEMBL2637808 0.83 NOS2 (0.42)
Proline SCHEMBL8941802 0.82 BLM (0.47)
SCHEMBL4336849 0.81 EPHX1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1711533-B1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby UNIV OHIO (US) 2013-12-11 EP claimed
EP-2133427-B1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby UNIV OHIO (US) 2013-12-11 EP claimed
US-20110230404-A1 Glycoproteins Produced in Plants and Methods of Their Use OHIO UNIVERSITY (US) 2011-09-22 US claimed
US-20100029548-A1 GLYCOPROTEINS PRODUCED IN PLANTS AND METHODS OF THEIR USE OHIO UNIVERSITY (US) 2010-02-04 US claimed
EP-2133427-A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby Ohio University (US) 2009-12-16 EP claimed
US-20250026819-A1 METHODS OF TREATMENT COMPRISING ANTIBODIES BINDING TO ALPHA7BETA1 INTEGRIN ANTIBODIES PLIANT THERAPEUTICS, INC. 2025-01-23 US disclosed
US-12134642-B2 Antibodies binding to α7β1 integrin antibodies and compositions thereof PLIANT THERAPEUTICS, INC. (US) 2024-11-05 US disclosed
US-11904004-B2 Anti-CD277 antibodies INSERM (FR) 2024-02-20 US disclosed
US-20240043541-A1 METHODS FOR TREATING HEMATOLOGIC CANCERS NOVARTIS AG (CH) 2024-02-08 US disclosed
US-11873486-B2 Modulating dsRNA editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-01-16 US disclosed
US-20240010749-A1 ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF MERCK PATENT GMBH (DE) 2024-01-11 US disclosed
US-20230416399-A1 METHODS FOR TREATING CANCER WITH ANTI-GD2/GD3 ANTIBODIES SARAGOVI HORACIO URI (CA) 2023-12-28 US disclosed
US-7378506-B2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins OHIO UNIVERSITY (US) 2008-05-27 US disclosed
WO-2008053330-A2 MONOCLONAL ANTIBODIES AGAINST THE HUMAN ANTI-MULLERIAN HORMONE TYPE II RECEPTOR (AMHR-II) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-05-08 WO disclosed
EP-1918304-A1 Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-05-07 EP disclosed
EP-1622635-A4 SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH GLYCOPROTEINS UNIV OHIO (US) 2008-01-23 EP disclosed
EP-1622635-A2 SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH GLYCOPROTEINS Ohio University (US) 2006-02-08 EP disclosed
US-20050074838-A1 Recombinant polypeptides comprising proline rich regions for use as tool in slow release drug delivery OHIO UNIVERSITY, TECHNOLOGY TRANSFER OFFICE, TECHNOLOGY 2005-04-07 US disclosed
WO-2004094590-A2 SYNTHETIC GENES FOR PLANT GUMS AND OTHER HYDROXYPROLINE-RICH GLYCOPROTEINS OHIO UNIVERSITY (US) 2004-11-04 WO disclosed
WO-2004034984-A2 CELL-SEEDED TISSUE-ENGINEERED POLYMERS FOR TREATMENT OF INTRACRANIAL ANEURYSMS THE GENERAL HOSPITAL CORPORATION (US) 2004-04-29 WO disclosed